Atopic dermatitis: Therapeutic concepts evolving from new pathophysiologic insights

作者：Jung Thomas^*; Stingl Georg

来源：Journal of Allergy and Clinical Immunology, 2008, 122(6): 1074-1081.

DOI：10.1016/j.jaci.2008.09.042

• Atopic dermatitis
• skin barrier function
• innate immune system
• adaptive immune system
• filaggrin
• T(H)2 cells
• T(H)17 cells
• immunotherapy
• proof-of-concept trial

Recent insights into the relevance of the epidermal barrier function and its interaction with components of the innate and adaptive immune responses in patients with atopic dermatitis (AD) give rise to a number of novel potential treatment options. In particular, the identification of loss-of-function mutations in the barrier protein filaggrin and of a diminished expression of certain antimicrobial peptides in AD skin stimulates new concepts to think beyond the T(H)1/T(H)2 paradigm. This review will focus on these most recent discoveries and will discuss new and corresponding proof-of-concept trials in patients with AD. It will further speculate on novel ways to restore the homeostasis among the 3 major components in AD skin suspected to be clinically relevant. (J Allergy Clin Immunol 2008;122:1074-81.)

• 出版日期2008-12